The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy
Toll-like receptors (TLRs) are a class of pattern recognition receptors that play a critical role in innate and adaptive immunity. Toll-like receptor agonists (TLRa) as vaccine adjuvant candidates have become one of the recent research hotspots in the cancer immunomodulatory field. Nevertheless, num...
Main Authors: | Lingling Huang, Xiaoyan Ge, Yang Liu, Hui Li, Zhiyue Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/6/1228 |
Similar Items
-
Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy
by: Samik Chakraborty, et al.
Published: (2023-10-01) -
Innate and Adaptive Responses of Intratumoral Immunotherapy with Endosomal Toll-Like Receptor Agonists
by: Fernando Torres Andón, et al.
Published: (2022-07-01) -
Invention and characterization of a systemically administered, attenuated and killed bacteria-based multiple immune receptor agonist for anti-tumor immunotherapy
by: Michael J. Newman
Published: (2024-11-01) -
Editorial: Updates on toll-like receptors in cancer immunity and immunotherapy
by: Bettina Hoden, et al.
Published: (2023-11-01) -
Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma
by: Yang Xun, et al.
Published: (2021-10-01)